# Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus

> **NCT02744378** · PHASE2 · COMPLETED · sponsor: **University of Peradeniya** · enrollment: 68 (actual)

## Conditions studied

- Oral Lichen Planus

## Interventions

- **DRUG:** Tacrolimus 0.1%
- **DRUG:** Clobetasol 0.05%

## Key facts

- **NCT ID:** NCT02744378
- **Lead sponsor:** University of Peradeniya
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-07
- **Final completion:** 2015-12
- **Target enrollment:** 68 (ACTUAL)
- **Last updated:** 2016-04-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02744378

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02744378, "Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02744378. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*